Ebola Virus

Ebola virus disease (EVD) is a severe disease caused by several species of Ebolavirus (EBOV), in the family Filoviridae. Prior to 2007, four species of EBOV had been identified, with two (Zaire ebolavirus and Sudan ebolavirus) having caused significant disease outbreaks in humans. The presence of a fifth EBOV virus species, Bundibugyo ebolavirus (BEBOV) was identified after an outbreak of EVD in the Bundibugyo District of western Uganda in 2007. Outbreaks of EVD are associated with person-to-person transmission after the virus is introduced into humans from a zoonotic reservoir. During outbreaks the virus is commonly transmitted through direct contact with infected persons or their bodily fluids. The onset of EVD is associated with nonspecific clinical symptoms, including fever, myalgia, headache, abdominal pain, nausea, vomiting, and diarrhoea.  In the later stages of disease, overt haemorrhage has been reported in up to 50% of cases.

The Zaire subtype of the EBOV family is currently the most important in relation to outbreaks of disease in humans.  This subtype has been responsible for the largest ever outbreak of EVD, which started in West Africa in 2014, and was finally declared over only in early 2016.

The Native Antigen Company supply highly purified viral antigens to support researchers working with EBOV including: –

Ebola Virus envelope glycoprotein (GP) (Zaire subtype)

Ebola Virus envelope glycoprotein (GP1) (Zaire subtype)

Ebola Virus envelope glycoprotein (GP1) (Bundibugyo subtype)

Ebola Virus secreted glycoprotein (sGP) (Bundibugyo subtype)

Reference

Adam MacNeil et al (2010). Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, Uganda. Emerg Infect Dis. 16(12): 1969–1972.

Showing all 5 results

We hold good stocks of all our antigens to ensure a rapid delivery service worldwide. We like to be in touch with our customers so please drop us a line or give us a call on +44 (0)1865 595230. To place an order, please email order@thenativeantigencompany.com and for further information including price inquiries, bulk preparations and contract services email: contact@thenativeantigencompany.com.

Menu